← Back to headlines
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal
Insilico Medicine and SK Biopharmaceuticals have announced a $2.5 billion deal focused on AI drug discovery, specifically targeting neuroimmune therapies.
22 Jun, 21:00 — 22 Jun, 21:00
Sources
Showing 1 of 1 sources
Related Stories
Rocket Lab Secures Spot on Space Force Contract, Viasat Selects for GEO Satellite
37m ago
Meta Faces Landmark Trial Over Social Media Addiction in Children
55m ago
Anthropic's Annual Revenue Run Rate Exceeds $65 Billion
1h ago
Google Acquires Spirit Airlines Business Data for $10 Million to Enhance AI
1h ago